|Mr. J. Michael Carmena||Vice Chairman & Principal Exec. Officer||207.11k||N/A||1956|
|Mr. Michael D. McNeil||Chief Financial Officer||178.76k||N/A||1966|
|Mr. Ronald T. Nixon||Exec. Chairman||N/A||N/A||1956|
|Mr. Callon Nichols||Director of Investor Relations||N/A||N/A||N/A|
|Dr. Jane A. Fore||Chief Medical Officer||N/A||N/A||N/A|
Sanara MedTech Inc. develops, markets, and distributes biotechnology products to physicians, hospitals, and clinics in the United States. It offers HemaQuell, a resorbable bone hemostat for bone healing; and CellerateRX surgical for healing. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was founded in 1982 and is based in Fort Worth, Texas.
Sanara MedTech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.